Immunotherapy Fits Everyone? Prognostic Markers for Immune-checkpoint-Inhibitor (ICI) in Non-small Cell Lung Cancer (NSCLC)

被引：0
作者：
Baptista De Almeida, S. [1 ]
Caleca, T. [1 ]
Silva, M. [1 ]
Honorio, M. [1 ]
Chaves, A. [1 ]
机构：
[1] Hosp Prof Doutor Fernando Fonseca, Med Oncol, Amadora, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
immune-checkpoint-inhibitor; prognostic markers; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P57.01
引用
收藏
页码：S1136 / S1136
页数：1
相关论文
共 50 条
[21]   Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer [J].
Minami, Seigo ;
Ihara, Shouichi ;
Ikuta, Shouko ;
Komuta, Kiyoshi .
WORLD JOURNAL OF ONCOLOGY, 2019, 10 (02) :90-100
[22]   Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer [J].
Bote, Helena ;
Mesas, Andres ;
Baena, Javier ;
Herrera, Mercedes ;
Paz-Ares, Luis .
EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) :289-300
[23]   Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis [J].
Wang, Yi ;
Lei, Yu ;
Zheng, Delai ;
Yang, Yanhui ;
Luo, Lei ;
Li, Ji ;
Xie, Xiaoyang .
PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
[24]   Emerging Immunotherapies in the Treatment of Non-small Cell Lung Cancer (NSCLC) The Role of Immune Checkpoint Inhibitors [J].
Langer, Corey J. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (04) :422-430
[25]   Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study [J].
Ziyi Xu ;
Xuezhi Hao ;
Ke Yang ;
Qi Wang ;
Jing Wang ;
Lin Lin ;
Fei Teng ;
Junling Li ;
Puyuan Xing .
Journal of Cancer Research and Clinical Oncology, 2022, 148 :3081-3089
[26]   Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study [J].
Xu, Ziyi ;
Hao, Xuezhi ;
Yang, Ke ;
Wang, Qi ;
Wang, Jing ;
Lin, Lin ;
Teng, Fei ;
Li, Junling ;
Xing, Puyuan .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) :3081-3089
[27]   STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC) [J].
Parums, D. V. .
DRUGS OF THE FUTURE, 2014, 39 (07) :469-477
[28]   PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) [J].
Angelicola, Stefania ;
Giunchi, Francesca ;
Ruzzi, Francesca ;
Frascino, Mariateresa ;
Pitzalis, Mary ;
Scalambra, Laura ;
Semprini, Maria Sofia ;
Pittino, Olga Maria ;
Cappello, Chiara ;
Siracusa, Irene ;
Chillico, Ilaria Candida ;
Di Noia, Martina ;
Turato, Cristian ;
De Siervi, Silvia ;
Lescai, Francesco ;
Ciavattini, Teresa ;
Lopatriello, Giulia ;
Bertoli, Luca ;
De Jonge, Hugo ;
Iamele, Luisa ;
Altimari, Annalisa ;
Gruppioni, Elisa ;
Ardizzoni, Andrea ;
Rossato, Marzia ;
Gelsomino, Francesco ;
Lollini, Pier-Luigi ;
Palladini, Arianna .
JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
[29]   Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer [J].
Xue, Chongxiang ;
Dong, Huijing ;
Chen, Ying ;
Lu, Xingyu ;
Zheng, Shuyue ;
Cui, Huijuan .
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06) :779-788
[30]   Highlights on immune checkpoint inhibitors in non-small cell lung cancer [J].
Shen, Meng ;
Ren, Xiubao .
TUMOR BIOLOGY, 2017, 39 (03)
12345